The Client on Isotretinoin Who Wants to Start Now
A 29-year-old man requests electrolysis on his cheeks and neck. He started isotretinoin 40 mg daily eight weeks ago for severe cystic acne and expects to continue for another four months. His cheeks are still actively inflamed with several tender nodules; the neck is clear. He read online that isotretinoin makes electrolysis dangerous and wants to know if he can start on the clear neck area now and do the cheeks later. He also asks whether he can stop the isotretinoin early so treatment can begin sooner. He has a wedding in five months.
1. How do you evaluate his request to treat the clear neck area now?
Read the worked answer
The concern with isotretinoin is impaired epithelial healing and altered skin fragility, which is a systemic effect rather than a local one, so a "clear area" is not automatically safe. The classic prohibition has been debated in dermatologic literature, but the conservative and widely taught position is to defer elective hair removal during treatment and for a period afterward, with the interval set by the prescribing physician. His active cystic disease and tender nodules also indicate his skin is not in a stable state.
The defensible plan is to defer treatment, explain the reasoning, and obtain the prescriber's input on timing. Do not present the deferral as a permanent bar; frame it as sequencing. His five-month wedding deadline is real but should not override healing risk. Offer a plan: complete the medical course, allow the recommended waiting period, then begin with a realistic estimate of what can be achieved before the date, including that multiple sessions and growth cycles mean full clearance by then is unlikely.
2. How do you respond to his question about stopping isotretinoin early?
Read the worked answer
Do not advise him to stop or alter a prescribed medication. That decision belongs to his prescriber and involves his acne severity, cumulative dose, and relapse risk. Explain why you are declining to advise: your role is to protect skin integrity during hair removal, not to manage his acne treatment. Suggest he raise the question with his dermatologist and offer to coordinate.
Document the conversation, including that he asked about stopping early and that you referred the decision to his physician. If he chooses to stop against advice and later returns, you would still want prescriber confirmation and evidence of skin stability before treating. Setting this boundary protects him and keeps your practice within scope.